HomeTRVI • NASDAQ
add
Trevi Therapeutics Inc
Previous close
$13.19
Year range
$2.36 - $13.78
Market cap
1.69B USD
Avg Volume
1.68M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.92M | -1.21% |
Net income | -11.80M | 10.87% |
Net profit margin | — | — |
Earnings per share | -0.08 | 38.46% |
EBITDA | -13.88M | 1.23% |
Effective tax rate | 0.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 194.93M | 197.63% |
Total assets | 199.36M | 189.31% |
Total liabilities | 9.57M | -3.73% |
Total equity | 189.79M | — |
Shares outstanding | 128.23M | — |
Price to book | 8.91 | — |
Return on assets | -17.07% | — |
Return on capital | -17.84% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.80M | 10.87% |
Cash from operations | -10.88M | -13.86% |
Cash from investing | -50.94M | -764.38% |
Cash from financing | 1.63M | -67.28% |
Net change in cash | -60.19M | -2,048.49% |
Free cash flow | -7.67M | -60.64% |
About
Founded
2011
Headquarters
Website
Employees
34
